<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>再摄取抑制剂 &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/zaishequyizhiji/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Thu, 12 Oct 2023 23:21:11 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>再摄取抑制剂 &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2021-2025年中国草酸艾司西酞普兰市场研究报告:2020市场销售额约3.29亿元</title>
		<link>https://www.yuanzhezixun.com/report-on-chinas-escitalopram-market/</link>
		
		<dc:creator><![CDATA[Timlee]]></dc:creator>
		<pubDate>Fri, 03 Sep 2021 05:25:50 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[5-HT]]></category>
		<category><![CDATA[H. Lundbeck]]></category>
		<category><![CDATA[Lexapro]]></category>
		<category><![CDATA[京卫制药]]></category>
		<category><![CDATA[再摄取抑制剂]]></category>
		<category><![CDATA[启程]]></category>
		<category><![CDATA[广场恐怖症]]></category>
		<category><![CDATA[康恩贝生物制药]]></category>
		<category><![CDATA[惊恐障碍]]></category>
		<category><![CDATA[抑郁症]]></category>
		<category><![CDATA[抗抑郁药物]]></category>
		<category><![CDATA[来士普]]></category>
		<category><![CDATA[泰齐]]></category>
		<category><![CDATA[洞庭药业]]></category>
		<category><![CDATA[灵北制药]]></category>
		<category><![CDATA[焦虑症]]></category>
		<category><![CDATA[百洛特]]></category>
		<category><![CDATA[百适可]]></category>
		<category><![CDATA[科伦药业]]></category>
		<category><![CDATA[草酸艾司西酞普兰]]></category>
		<category><![CDATA[草酸艾司西酞普兰区域分析]]></category>
		<category><![CDATA[草酸艾司西酞普兰市场份额]]></category>
		<category><![CDATA[草酸艾司西酞普兰市场竞争]]></category>
		<category><![CDATA[草酸艾司西酞普兰市场细分]]></category>
		<category><![CDATA[草酸艾司西酞普兰市场规模]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=26884</guid>

					<description><![CDATA[据CRI元哲市场调研，预计2021-2025年，中国草酸艾司西酞普兰的市场规模有望出现恢复性增长。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
